Cargando…
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/ https://www.ncbi.nlm.nih.gov/pubmed/32093043 http://dx.doi.org/10.3390/jcm9020571 |
_version_ | 1783506681318080512 |
---|---|
author | Boldog, Péter Tekeli, Tamás Vizi, Zsolt Dénes, Attila Bartha, Ferenc A. Röst, Gergely |
author_facet | Boldog, Péter Tekeli, Tamás Vizi, Zsolt Dénes, Attila Bartha, Ferenc A. Röst, Gergely |
author_sort | Boldog, Péter |
collection | PubMed |
description | We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number [Formula: see text]). We found that in countries with low connectivity to China but with relatively high [Formula: see text] , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low [Formula: see text] benefit the most from policies that further reduce [Formula: see text]. Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing. |
format | Online Article Text |
id | pubmed-7073711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70737112020-03-19 Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China Boldog, Péter Tekeli, Tamás Vizi, Zsolt Dénes, Attila Bartha, Ferenc A. Röst, Gergely J Clin Med Article We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number [Formula: see text]). We found that in countries with low connectivity to China but with relatively high [Formula: see text] , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low [Formula: see text] benefit the most from policies that further reduce [Formula: see text]. Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing. MDPI 2020-02-19 /pmc/articles/PMC7073711/ /pubmed/32093043 http://dx.doi.org/10.3390/jcm9020571 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Boldog, Péter Tekeli, Tamás Vizi, Zsolt Dénes, Attila Bartha, Ferenc A. Röst, Gergely Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title_full | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title_fullStr | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title_full_unstemmed | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title_short | Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China |
title_sort | risk assessment of novel coronavirus covid-19 outbreaks outside china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/ https://www.ncbi.nlm.nih.gov/pubmed/32093043 http://dx.doi.org/10.3390/jcm9020571 |
work_keys_str_mv | AT boldogpeter riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina AT tekelitamas riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina AT vizizsolt riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina AT denesattila riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina AT barthaferenca riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina AT rostgergely riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina |